WallStSmart

Medtronic PLC (MDT)vsQualcomm Incorporated (QCOM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Qualcomm Incorporated generates 25% more annual revenue ($44.49B vs $35.48B). QCOM leads profitability with a 22.3% profit margin vs 13.0%. QCOM appears more attractively valued with a PEG of 0.82. QCOM earns a higher WallStSmart Score of 71/100 (B).

MDT

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 6.7Quality: 5.0

QCOM

Strong Buy

71

out of 100

Grade: B

Growth: 5.3Profit: 8.5Value: 6.7Quality: 7.5
Piotroski: 4/9Altman Z: 3.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTUndervalued (+27.7%)

Margin of Safety

+27.7%

Fair Value

$107.79

Current Price

$76.15

$31.64 discount

UndervaluedFair: $107.79Overvalued
QCOMUndervalued (+8.0%)

Margin of Safety

+8.0%

Fair Value

$220.25

Current Price

$219.09

$1.16 discount

UndervaluedFair: $220.25Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$100.09B9/10

Large-cap with strong market position

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

QCOM6 strengths · Avg: 9.5/10
Market CapQuality
$230.92B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
36.1%10/10

Every $100 of equity generates 36 in profit

EPS GrowthGrowth
173.0%10/10

Earnings expanding 173.0% YoY

Altman Z-ScoreHealth
3.1710/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
22.3%9/10

Keeps 22 of every $100 in revenue as profit

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

QCOM2 concerns · Avg: 3.0/10
Price/BookValuation
10.2x4/10

Trading at 10.2x book value

Revenue GrowthGrowth
-3.5%2/10

Revenue declined 3.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bull Case : QCOM

The strongest argument for QCOM centers on Market Cap, Return on Equity, EPS Growth. Profitability is solid with margins at 22.3% and operating margin at 22.1%. PEG of 0.82 suggests the stock is reasonably priced for its growth.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : QCOM

The primary concerns for QCOM are Price/Book, Revenue Growth.

Key Dynamics to Monitor

MDT profiles as a value stock while QCOM is a declining play — different risk/reward profiles.

QCOM carries more volatility with a beta of 1.49 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

QCOM scores higher overall (71/100 vs 58/100), backed by strong 22.3% margins. MDT offers better value entry with a 27.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Qualcomm Incorporated

TECHNOLOGY · SEMICONDUCTORS · USA

Qualcomm is an American multinational corporation headquartered in San Diego, California, and incorporated in Delaware. It creates semiconductors, software, and services related to wireless technology. It owns patents critical to the 5G, 4G, CDMA2000, TD-SCDMA and WCDMA mobile communications standards.

Visit Website →

Want to dig deeper into these stocks?